继发性甲状旁腺功能亢进的介入和手术治疗进展  

Progress in interventional and surgical treatment for secondary hyperparathyroidism

作　　者：刁宗礼[1] 王丽妍[1] 刘莎[1] 刘文虎[1] 

机构地区：[1]首都医科大学附属北京友谊医院肾内科,北京100050

出　　处：《大连医科大学学报》2016年第3期298-301,共4页Journal of Dalian Medical University

基　　金：国家自然科学基金项目(81300607);北京市科学技术委员会科技计划重大项目(D131100004713001)

摘　　要：继发性甲状旁腺功能亢进(SHPT)是慢性肾脏病尤其是透析患者的常见并发症,可增加患者的心血管事件与死亡发生率。目前SHPT的主要治疗药物为维生素D及其类似物。但部分患者对药物治疗抵抗,或因钙磷控制欠佳难以接受药物治疗,应考虑予以介入治疗和手术切除等方法。本文就近年来SHPT的介入和手术治疗最新进展进行综述。Secondary hyperparathyroidism is the common complication in patients with hemodialysis which is associated with high prevalence of cardio-cerebral vascular events and high mortality. Although active vitamin D and its analogues are the classic treatment,some patients are still resistant to these drugs,and intervention and surgery should be considered in these patients. The purpose of this article is to review the progress in interventional and surgical treatment for secondary hyperparathyroidism.

关 键 词：继发性甲状旁腺功能亢进 射频消融 微波消融 激光消融 手术治疗 

分 类 号：R692[医药卫生—泌尿科学] R582.1[医药卫生—外科学]